Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87,441,936
-
Total 13F shares
-
17,791,143
-
Share change
-
-30,888
-
Total reported value
-
$126,852,000
-
Price per share
-
$7.13
-
Number of holders
-
27
-
Value change
-
-$752,301
-
Number of buys
-
17
-
Number of sells
-
9
Institutional Holders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) as of Q1 2022
As of 31 Mar 2022,
Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,791,143 shares.
The largest 10 holders included
FMR LLC, Redmile Group, LLC, VANGUARD GROUP INC, Velan Capital Investment Management LP, Parian Global Management LP, Triatomic Management LP, Saba Capital Management, L.P., MILLENNIUM MANAGEMENT LLC, ExodusPoint Capital Management, LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.